Glenmark Pharmaceuticals Inc., USA recalls
Every recall we track for Glenmark Pharmaceuticals Inc., USA — 141 in all, from 2017–2026 — plus the complaints and injury reports the public filed about them. 8 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Glenmark Pharmaceuticals Inc., USA more than doubled in 2025 (73, up from 25 in 2024). 6% rated “stop using now”.
All FDA recall records for Glenmark Pharmaceuticals Inc., USA since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 1 | 0 | 1 |
| 2018 | 0 | 0 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 8 | 4 | 13 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 2 | 5 | 8 |
| 2022 | 0 | 1 | 5 | 3 | 9 |
| 2023 | 0 | 1 | 5 | 1 | 7 |
| 2024 | 2 | 5 | 9 | 9 | 25 |
| 2025 | 4 | 4 | 15 | 50 | 73 |
| 2026 (to date) | 0 | 0 | 2 | 0 | 2 |
Most common reasons for Glenmark Pharmaceuticals Inc., USA recalls
What to do if you have a recalled Glenmark Pharmaceuticals Inc., USA product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Glenmark Pharmaceuticals Inc., USA recalls
55 shown- Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc.,
Glenmark Pharmaceuticals recalls 15% Azelaic Acid Gel tubes with grainy texture. Product quality complaints reported for abnormal consistency. Check NDC 68462-626-52 and lot numbers for affected items.
GlenmarkJul 23, 2026 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg, 0.75mg/0.035mg, 1 mg/0.0.35mg, 3 Blister
Glenmark Pharmaceuticals recalls Alyacen birth control tablets with impurities. These pills may have unsafe levels of impurities that could affect safety. Stop using if you have the specific lot numbers listed.
GlenmarkMay 27, 2026 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only,
Glenmark Pharmaceuticals recalls 4mg orally disintegrating ondansetron tablets due to blister packs not fully sealed, risking tablets falling out. Rx-only product sold in 30-tablet blister packs.
GlenmarkDec 30, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packaged as (a) 30-count bottles,
Glenmark Pharmaceuticals recalls 2.5mg/6.25mg Bisoprolol Fumarate and Hydrochlorothiazide tablets due to traces of ezetimibe found in some batches. Check NDC numbers for affected lots.
Glenmark PharmaceuticalsNov 21, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya
Glenmark Pharmaceuticals recalls 20 mg Nebivolol tablets due to cross contamination risk. Affected lots manufactured in India with specific expiration date. Consumers should check product details and contact for guidance.
GlenmarkNov 18, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals is recalling 13,824 tubes of Azelaic Acid Gel 15% due to CGMP deviations causing a gritty texture. Check your batch number.
Glenmark PharmaceuticalsSep 17, 2025 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg, 3
Glenmark Pharmaceuticals recalls Viorele and Ethinyl Estradiol tablets due to failed impurities/degradation specs. These birth control pills may pose health risks if impurities are present. Check NDC 68462-318-29 and batch 20230733 for affected products.
GlenmarkSep 3, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals
Glenmark Pharmaceuticals recalls 400mg theophylline extended-release tablets with failed dissolution test results. These Rx-only tablets may not release medication properly over time. Consumers should contact the manufacturer for details.
GlenmarkAug 8, 2025 - Stop using nowDrug
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets, USP, 12.5 mg, 500-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd,
Glenmark Pharmaceuticals recalls 12.5 mg Carvedilol tablets due to nitrosamine impurity exceeding safe levels. Consumers with the specific NDC 68462-164-05 lot 19243202 should stop using and contact for details.
GlenmarkAug 7, 2025 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets, USP, 25 mg, 500 Tablets per carton, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot
Glenmark Pharmaceuticals recalls 25mg Carvedilol tablets due to NNCI impurity exceeding FDA limits. Affected lots manufactured in India for US sale. Consumers should contact pharmacy for safe alternatives.
GlenmarkAug 6, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd.,
Glenmark Pharmaceuticals recalls 10mg/40mg Ezetimibe and Simvastatin tablets due to impurity issues detected during long-term stability testing. Affected lots may pose risks if stored beyond expiration.
GlenmarkMay 19, 2025 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark
Glenmark Pharmaceuticals recalls specific lots of Theophylline 600 mg extended-release tablets because they fail dissolution tests, potentially affecting drug potency.
GlenmarkMay 15, 2025 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Cetirizine Hydrochloride Tablets, USP, 10mg, 365-count packs, Rx Only, Manufactured for: Glenmark Therapeutics Inc.,
Glenmark Pharmaceuticals recalls 10mg cetirizine tablets due to CGMP deviations. Affected lots sold via Amazon and Walmart. Consumers should contact pharmacy for replacement.
GlenmarkMar 13, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark
Glenmark Pharmaceuticals recalls 100mg chlorpromazine hydrochloride tablets (NDC 68462-864-01) with a nitrosated impurity that may pose health risks. Affected lots 17232222 and 17232237 expire 10/31/2025.
GlenmarkMar 11, 2025 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd., Manufactured
Glenmark recalls specific lots of Carvedilol Tablets USP 25 mg due to CGMP deviations and an impurity above safe limits. Check your bottle's lot number.
Glenmark PharmaceuticalsFeb 28, 2025 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ,
Glenmark recalls 80mg Atomoxetine Capsules due to N-Nitroso impurity exceeding FDA limits. Affected lots from 19234153 to 19244014 with specific expiration dates. No remedy stated in recall notice.
GlenmarkJan 29, 2025 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol Tablets, USP, 12.5 mg, Rx only, a)500 Tablets, NDC 68462-164-05; b) 100 Tablets, NDC 68462-164-01,
Glenmark Pharmaceuticals recalls specific lots of Carvedilol Tablets, USP, 12.5 mg due to CGMP deviations and failing impurity limits.
Glenmark PharmaceuticalsJan 22, 2025 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals
Glenmark Pharmaceuticals recalls 100-count chlorpromazine tablets (NDC 68462-861-01) for potential N-Nitroso-Desmethyl Chlorpromazine impurity exceeding FDA limits. Patients should consult their doctor.
GlenmarkDec 11, 2024 - Stop using nowDrug
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd
Glenmark Pharmaceuticals recalls 90mg Diltiazem capsules due to potential harmful impurity. Affected lots manufactured in 2024-2025. Stop using immediately if you have these capsules.
GlenmarkNov 1, 2024 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Ciclopirox Gel 0.77%, For Dermatologic Use Only, Not for Use in Eyes, Rx Only, a) 30 gm Tube, NDC 68462-0455-35; b) 45
Glenmark Pharmaceuticals recalls Ciclopirox Gel 0.77% tubes due to broken seal complaints. This medication is for dermatological use only and requires a prescription. Affected products include 30g, 45g, and 100g tubes with specific NDC numbers.
Glenmark PharmaceuticalsSep 30, 2024 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered
Glenmark Pharmaceuticals recalls specific lots of Ryaltris nasal spray because the dip tube may be clogged, preventing the medication from dispensing.
GlenmarkSep 24, 2024 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Mupirocin Ointment, USP, 2%, 22 g, Rx only, Manufactured by: Glenmark Pharmaceuticals, Ltd., Colvale-Bardez, Goa
Glenmark Pharmaceuticals recalls 2% mupirocin ointment (22g) due to subpotent drug levels. Rx only product with specific lot numbers and expiration dates. Consumers should check their product details.
GlenmarkAug 30, 2024 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Indomethacin Extended-Release Capsules, USP, 75 mg, packaged in a) 60-count bottle (NDC 68462-325-60) and b) 90-count
Glenmark recalls Indomethacin Extended-Release Capsules, USP, 75 mg due to failed dissolution specifications. Check your lot number and NDC for details.
Glenmark PharmaceuticalsJul 31, 2024 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Glenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez,
Glenmark Pharmaceuticals recalls 14,004 cartons of Azelaic Acid Gel 15% due to CGMP deviations. Check your lot number and expiration date.
GlenmarkJul 22, 2024 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium Tablets, USP 80mg, packaged in a) 90-count bottle, NDC 68462-198-90; b) 500-count bottle, NDC
Glenmark Pharmaceuticals recalls 80mg Pravastatin Sodium Tablets due to failed dissolution specifications. These tablets may not work as intended. Check NDC numbers and expiration dates for affected lots.
GlenmarkJun 28, 2024 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 100-count bottle, Rx Only, Manufactured by:
Glenmark Pharmaceuticals recalls Potassium Chloride Extended-Release Capsules due to CGMP deviations. Check your lot numbers and expiration dates for affected batches.
GlenmarkMay 30, 2024 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark
Glenmark recalls 10mg Rizatriptan Benzoate orally dissolving tablets due to N-Nitroso Desmethyl Rizatriptan impurity exceeding FDA limits. Affected lots from 19223402 to 19232492.
GlenmarkMay 13, 2024 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Rizatriptan Benzoate Tablets USP, 5mg, 18 (3 X 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc.,
Glenmark Pharmaceuticals recalls 5mg Rizatriptan Benzoate tablets due to N-Nitroso Desmethyl Rizatriptan impurity exceeding FDA limits. Affected lots manufactured in India with specific NDC and expiration dates.
GlenmarkMay 10, 2024 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,
Glenmark recalls 120mg Diltiazem capsules due to failed dissolution specifications. Rx-only medication may not release properly in the body. Contact for return instructions.
GlenmarkApr 17, 2024 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only,
Glenmark Pharmaceuticals recalls 120mg Diltiazem capsules with failed dissolution test. Do not use if expired or from specific lot. Contact for details.
GlenmarkMar 26, 2024 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by:
Glenmark recalls specific lots of Fluocinolone Acetonide Oil ear drops because the isopropyl alcohol assay failed specifications. Check your lot numbers.
Glenmark PharmaceuticalsJan 4, 2024 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez,
Glenmark Pharmaceuticals recalls 250mg Naproxen tablets that may be mislabeled as Indomethacin. This labeling error could lead to incorrect medication use. Contact for details.
GlenmarkNov 7, 2023 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals
Glenmark Pharmaceuticals recalls 500mg Ranolazine Extended-Release Tablets due to failed dissolution specifications. Rx-only medication with specific lot number and expiration date.
GlenmarkOct 23, 2023 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20mg, Packaged as (a) 30-count bottle, NDC 68462-390-30; (b)
Glenmark Pharmaceuticals recalls 20mg esomeprazole capsules due to impurities detected at 18 months in stability testing. Consumers should check NDC 68462-390-30 or 68462-390-10 bottles for affected lots.
GlenmarkOct 23, 2023 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 5mg/6.25mg, 100-count Bottle, RX only, Manufactured by:
Glenmark recalls 5mg/6.25mg bisoprolol and hydrochlorothiazide tablets due to failed impurities tests. RX-only 100-count bottles with specific NDC and lot numbers. No remedy stated in recall notice.
GlenmarkOct 20, 2023 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals
Glenmark Pharmaceuticals recalls specific lots of Deferasirox Tablets for Oral Suspension, 500mg, because they failed dissolution specifications.
Glenmark PharmaceuticalsOct 20, 2023 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only,
Glenmark Pharmaceuticals recalls 2 mg/180 mg extended-release tablets due to subpotent assay results. Rx-only product with NDC 68462-295-01. No remedy stated in official notice.
GlenmarkAug 14, 2023 - Use cautionDrug
Glenmark Pharmaceuticals Inc., USA recalls Tacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDC
Glenmark Pharmaceuticals recalls 0.1% Tacrolimus Ointment tubes that may split from side seam. Stop using immediately to avoid injury.
Glenmark PharmaceuticalsJul 11, 2022 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Desmopressin Acetate Tablets, 0.2 mg, 100-count bottles, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN
Glenmark Pharmaceuticals recalls 0.2 mg Desmop: CGMP deviations may affect safety. Rx-only tablets with specific lot number and expiration date.
GlenmarkJun 29, 2022 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, 30 Tablets, Rx Only, Manufactured by: Glenmark
Glenmark recalls specific batches of Telmisartan and Hydrochlorothiazide tablets due to difficult blister opening and tablet breaks. Affected lots have expiration dates through August 2023.
GlenmarkJun 29, 2022 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Aspirin and Extended-Release Dipyridamole Capsules, 25mg/200 mg, 60-count bottle, Rx Only, Manufactured for: Glenmark
Glenmark recalls aspirin and dipyridamole capsules due to capsule breakage. Affected products include specific lot numbers and expiration dates. Consumers should check their product details and contact the manufacturer.
GlenmarkJun 29, 2022 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Mometasone Furoate, Topical Solution USP, 0.1 % Lotion, a) 30 ml-bottle (NDC 68462-385-37), b) 60 ml-bottle (NDC
Glenmark Pharmaceuticals recalls 0.1% Mometasone Furoate lotion due to defective container. Rx-only product with specific lot numbers and expiration dates. Consumers should check their bottles for affected lots.
GlenmarkJun 16, 2022 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Zonisamide Capsules, USP, 50 mg, packaged in 100-count bottles, Rx only, Manufactured by: Glenmark Pharmaceuticals,
Glenmark Pharmaceuticals recalls 50mg Zonisamide Capsules due to cGMP deviations. This may affect safety in manufacturing. Check your product details to see if you are affected.
Glenmark PharmaceuticalsApr 25, 2022 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx
Glenmark Pharmaceuticals recalls Fulvestrant injection due to lack of sterility assurance. This medication may contain contaminants that could cause infection. Affected products have specific NDC numbers and expiration dates.
GlenmarkAug 27, 2021 - UnratedDrug
Glenmark Pharmaceuticals Inc., USA recalls Glenmark Ranitidine Tablets USP 300 mg Rx Only 250 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals recalls 300 mg ranitidine tablets due to detected NDMA impurity. This may pose health risks. Consumers should check NDC numbers and contact the company for details.
GlenmarkDec 17, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100 g pack (NDC 68462-608-94), Rx only,
Glenmark Pharmaceuticals recalls 0.05% Clobetasol Propionate Foam due to defective delivery system causing it to not foam or leak liquid. Rx only products with specific NDCs and expiration dates are affected.
GlenmarkNov 15, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Estradiol Vaginal Inserts USP, 10 mcg, packaged in a) 8-count Vaginal Inserts (with disposable applicators) per carton
Glenmark Pharmaceuticals recalls Estradiol Vaginal Inserts (10 mcg) due to difficulty pushing the plunger of the applicator. This is a drug recall for Rx-only products with specific batch numbers and NDC codes.
GlenmarkOct 22, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%, 15 gram tubes, Rx only, Manufactured by: Glenmark
Glenmark recalls 15g Clotrimazole and Betamethasone Dipropionate Cream USP 1%/0.05% tubes due to liquidy texture complaints from temperature abuse.
GlenmarkAug 7, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Mometasone Furoate Cream USP, 0.1%, packaged in a) 15gram tubes (NDC 68462-192-17) and b) 45 gram tubes (NDC
Glenmark Pharmaceuticals is recalling specific lots of Mometasone Furoate Cream USP 0.1% because complaints indicate the product has a gritty texture.
Glenmark PharmaceuticalsJul 23, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Estradiol Vaginal Inserts USP 10 mcg, packaged in box of 8 Vaginal Inserts (with disposable applicators), Rx Only,
Glenmark Pharmaceuticals recalls Estradiol Vaginal Inserts USP 10 mcg (box of 8) due to defective plunger that may not function properly. This is a prescription-only product with specific lot and expiration details.
GlenmarkJun 3, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Pravastatin Sodium Tablets USP, 20 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot
Glenmark Pharmaceuticals recalls 20mg Pravastatin tablets due to foreign tablets in some bottles. This may cause harm if taken. Check your bottle's NDC 68462-196-05 and lot number 17181491.
GlenmarkMar 25, 2019 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Estradiol Vaginal Inserts, USP, 10 mcg, Rx only, packaged in a) 8 count (NDC 68462-711-71) and b) 18 count (NDC
Glenmark Pharmaceuticals recalls Estradiol Vaginal Inserts (10 mcg) due to customer reports of plunger malfunction in applicators. Affected units have specific NDC numbers and batch dates.
GlenmarkDec 26, 2018 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark
Glenmark recalls Aprepitant 40mg capsules due to customer reports of missing capsules in blister packs. Affected units have specific NDC and lot numbers. Consumers should check their packaging for the recall details.
GlenmarkNov 27, 2018 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Indomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.,
Glenmark Pharmaceuticals recalls 50mg indomethacin capsules with incorrect adult dosage instructions. Labels state 'one or two capsules 2-3 times daily' instead of 'one capsule 2-3 times daily'. This could lead to overdose risk if taken as instructed.
GlenmarkMar 19, 2018 - Lower riskDrug
Glenmark Pharmaceuticals Inc., USA recalls Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village
Glenmark Pharmaceuticals recalls 0.1% Mometasone Furoate Cream due to gritty texture complaints. This Rx-only cream may cause irritation. Check NDC 68462019255 for affected batches.
GlenmarkNov 20, 2017
Glenmark Pharmaceuticals Inc., USA recall questions
How many recalls has Glenmark Pharmaceuticals Inc., USA had?
141 recalls from Glenmark Pharmaceuticals Inc., USA are on record with U.S. safety agencies, from 2017–2026.
What is the most recent Glenmark Pharmaceuticals Inc., USA recall?
Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc.,, dated Jul 23, 2026. Every Glenmark Pharmaceuticals Inc., USA recall is listed on this page, newest first.
Why are Glenmark Pharmaceuticals Inc., USA products recalled?
The most common reasons on record: CGMP Deviations (49); CGMP Deviations: Presence of NDMA impurity detected in product. (6); Failed Dissolution Specifications (4); cGMP deviations (3).
What should I do if I have a recalled Glenmark Pharmaceuticals Inc., USA product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Glenmark Pharmaceuticals Inc., USA recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.